Proteon Therapeutics Inc. (PRTO) Stock Price & Overview

NASDAQ:PRTO

Current stock price

0.8352
+0.19 (+28.45%)
At close:
0.712
-0.12 (-14.75%)
After Hours:

The current stock price of PRTO is 0.8352 null. Today PRTO is up by 28.45%. In the past month the price increased by 161%. In the past year, price decreased by -66.46%.

PRTO Key Statistics

52-Week Range0.22 - 3.94
Current PRTO stock price positioned within its 52-week range.
1-Month Range0.275 - 0.955
Current PRTO stock price positioned within its 1-month range.
Market Cap
18.524M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.96
Dividend Yield
N/A

PRTO Stock Performance

Today
+28.45%
1 Week
+79.30%
1 Month
+161.00%
3 Months
+229.21%
Longer-term
6 Months +85.31%
1 Year -66.46%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

PRTO Stock Chart

Proteon Therapeutics Inc. / PRTO Daily stock chart

PRTO Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to PRTO. When comparing the yearly performance of all stocks, PRTO is one of the better performing stocks in the market, outperforming 97.6% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
PRTO Full Technical Analysis Report

PRTO Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to PRTO. PRTO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
PRTO Full Fundamental Analysis Report

PRTO Earnings

Next Earnings DateN/A
Last Earnings DateN/A
PRTO Earnings History

PRTO Forecast & Estimates


Analysts
Analysts73.4
Price TargetN/A
EPS Next Y32.17%
Revenue Next YearN/A
PRTO Forecast & Estimates

PRTO Financial Highlights

Over the last trailing twelve months PRTO reported a non-GAAP Earnings per Share(EPS) of -0.9600000000000001. The EPS increased by 18.64% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-18.64M
Industry RankSector Rank
PM (TTM) N/A
ROA -193.21%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%68%
Sales Q2Q%N/A
EPS 1Y (TTM)18.64%
Revenue 1Y (TTM)N/A
PRTO financials

PRTO Ownership

Ownership
Inst Owners23.03%
Shares22.18M
Float7.31M
Ins Owners31.18%
Short Float %N/A
Short RatioN/A
PRTO Ownership

About PRTO

Company Profile

Proteon Therapeutics Inc. is a biopharmaceutical company. The Company is developing pharmaceuticals to address the medical needs of patients with kidney and vascular diseases. It is developing PRT-201, a recombinant human elastase, applied in a single treatment to the external surface of arteries and veins during an open surgical procedure or an endovascular intervention. Proteon Therapeutics Inc. is headquartered in Waltham, Mass.

Company Info

Proteon Therapeutics Inc.

200 WEST STREET

WALTHAM MA 02451

CEO: Timothy P. Noyes

Phone: 781-890-0102

Proteon Therapeutics Inc. / PRTO FAQ

What does Proteon Therapeutics Inc. do?

Proteon Therapeutics Inc. is a biopharmaceutical company. The Company is developing pharmaceuticals to address the medical needs of patients with kidney and vascular diseases. It is developing PRT-201, a recombinant human elastase, applied in a single treatment to the external surface of arteries and veins during an open surgical procedure or an endovascular intervention. Proteon Therapeutics Inc. is headquartered in Waltham, Mass.


What is the current price of PRTO stock?

The current stock price of PRTO is 0.8352 null. The price increased by 28.45% in the last trading session.


Does Proteon Therapeutics Inc. pay dividends?

PRTO does not pay a dividend.


What is the ChartMill technical and fundamental rating of PRTO stock?

PRTO has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Should I buy PRTO stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PRTO.